home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How HIV Keeps Hiding

  December, 14 2005 10:52
your information resource in human molecular genetics
Researchers have found a way to explain how the human immunodeficiency virus (HIV) can be kept dormant and hidden in immune cells. Their findings, published online by The EMBO Journal suggest new potential therapeutic approaches for viral eradication from infected patients.

Current combined antiviral therapies that target essential components of replicating HIV fail to achieve complete eradication of the virus from infected patients. This is due in part to the presence of rare cells harboring silent copies of the HIV virus - a dangerous reservoir of literally "invisible" virus that might potentially reactivate and seed a new infection.

Warner C. Greene and colleagues report on a significant progress towards the understanding of the molecular mechanisms responsible for maintenance of HIV latency. Specifically, the team demonstrates that viral gene expression is actively repressed by the inhibitory NF-kappaB p50 protein. This inhibition is mediated by an enzyme called HDAC1, which is capable of shutting down gene expression in its vicinity. Interestingly, counteracting the inhibitory effect of HDAC1 by pharmacological agents is not sufficient to reactivate dormant HIV. To reach full viral gene expression, additional help by the viral protein Tat is required.

These findings suggest that combination of HDAC inhibitors and Tat might be a potential strategy to awaken dormant HIV and eliminate the latent reservoir of "invisible" virus.

Author contact:

Warner C Greene (University of California, San Francisco, CA, USA)
Email: wgreene@gladstone.ucsf.edu

Editorial contact:

Thomas Lemberger (The EMBO Journal, Heidelberg, Germany)
E-mail: t.lemberger@embojournal.org

Abstract available online.

(C) The EMBO Journal press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.